Granules facility passes USFDA inspection

All of Granules' facilities Have reportedly been approved by leading regulatory agencies

Hyderabad-based pharmaceutical company Granules India Limited stated that its paracetamol facility successfully passed a US Food and Drug Administration (USFDA) inspection.

The facility, according to the company's press release, has the world's largest single active pharmaceutical ingredients (API) production line by volume.

In fact, all of Granules' facilities were said have been approved by leading regulatory agencies including the USFDA, EDQM ( European Directorate for the Quality of Medicines), Health Canada and Korean FDA.